Pharming (PHAR) Gross Profit (2020 - 2026)
Pharming (PHAR) recorded Gross Profit of $102.20 in Q3 2026, up 13.3% from $90.20 a year earlier but down 100.0% from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Gross Profit (2020 - 2026) Analysis & Trends
On a TTM basis, Pharming's Gross Profit came in at $207.27 million as of Sep 30, 2026, down 8.2% year-over-year; for FY2025, it came in at $330.63 million, up 26.3% from FY2024.
- Annual Gross Profit has increased for four straight years, with a five-year compound annual growth rate of 11.9% (FY2020 to FY2025).
- Across earlier years, Gross Profit came in at $261.8 million in FY2024 (+18.9%), $220.1 million in FY2023 (+17.0%), $188.06 million in FY2022 (+5.8%) and $177.73 million in FY2021 (-5.8%).
- Quarterly Gross Profit has ranged from $80.50 in Q4 2024 to $155.02 million in Q2 2025 over the past five years.
- On a year-over-year basis, Gross Profit rose in four of the last eight quarters, with an average decline of 13.7%.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 90.1% in Q2 2023, against a decline of 100.0% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $141.47 million (Q2 2026), $65.8 million (Q1 2026) and $85.40 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Pharming | 898.85 Mn | 429.52 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 102.20 |
| Jun 30, 2026 | 141.47 Mn |
| Mar 31, 2026 | 65.80 Mn |
| Dec 31, 2025 | 85.40 |
| Sep 30, 2025 | 90.20 |
| Jun 30, 2025 | 155.02 Mn |
| Mar 31, 2025 | 70.77 Mn |
| Dec 31, 2024 | 80.50 |
| Sep 30, 2024 | 68.00 Mn |
| Jun 30, 2024 | 113.31 Mn |
| Mar 31, 2024 | 47.20 Mn |
| Dec 31, 2023 | 74.10 Mn |
| Sep 30, 2023 | 58.37 Mn |
| Jun 30, 2023 | 87.64 Mn |
| Mar 31, 2023 | 38.47 Mn |
| Dec 31, 2022 | 48.30 Mn |
| Sep 30, 2022 | 51.90 Mn |
| Jun 30, 2022 | 46.10 Mn |
| Mar 31, 2022 | 41.70 Mn |
| Dec 31, 2021 | 130.60 Mn |
API Access
Pharming Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();